
Molecule: TRICHLORFON
ChEMBL ID: CHEMBL167150
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: QUINAPRIL HYDROCHLORIDE
ChEMBL ID: CHEMBL1201011
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: TRANDOLAPRIL
ChEMBL ID: CHEMBL1519
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1996

Molecule: MOEXIPRIL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200534
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1995

Molecule: ENALAPRILAT
ChEMBL ID: CHEMBL3989406
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1988

Molecule: RAMIPRIL
ChEMBL ID: CHEMBL1168
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: FOSINOPRIL SODIUM
ChEMBL ID: CHEMBL3039596
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: BENAZEPRIL HYDROCHLORIDE
ChEMBL ID: CHEMBL1694
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: CAPTOPRIL
ChEMBL ID: CHEMBL1560
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: PERINDOPRIL ERBUMINE
ChEMBL ID: CHEMBL1200343
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1993

Molecule: LISINOPRIL
ChEMBL ID: CHEMBL419213
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: ENALAPRIL MALEATE
ChEMBL ID: CHEMBL1200659
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1985

Molecule: SPIRAPRIL HYDROCHLORIDE
ChEMBL ID: CHEMBL1200831
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1994

Molecule: PERINDOPRIL ARGININE
ChEMBL ID: CHEMBL3544986
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015

Molecule: CILAZAPRIL
ChEMBL ID: CHEMBL515606
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: IMIDAPRIL
ChEMBL ID: CHEMBL317094
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1993

Molecule: DELAPRIL
ChEMBL ID: CHEMBL589583
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ILEPATRIL
ChEMBL ID: CHEMBL3187812
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CLOPIDOGREL BISULFATE
ChEMBL ID: CHEMBL1083385
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: TICLOPIDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1717
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1991

Molecule: TICAGRELOR
ChEMBL ID: CHEMBL398435
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2010

Molecule: PRASUGREL HYDROCHLORIDE
ChEMBL ID: CHEMBL1201773
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: CANGRELOR TETRASODIUM
ChEMBL ID: CHEMBL1097279
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015

Molecule: ELINOGREL
ChEMBL ID: CHEMBL2103828
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: REGRELOR DISODIUM
ChEMBL ID: CHEMBL261244
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SELATOGREL
ChEMBL ID: CHEMBL4297589
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ENSITUXIMAB
ChEMBL ID: CHEMBL1743013
Mechanism of Action: OTHER
Max Phase: 2.0
Molecule Type: Antibody

Molecule: YTTRIUM Y 90 CLIVATUZUMAB TETRAXETAN
ChEMBL ID: CHEMBL2108708
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody drug conjugate

Molecule: CLIVATUZUMAB TETRAXETAN
ChEMBL ID: CHEMBL3301586
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate
